← Leaderboards
Emily Parker Hyle
Massachusetts General Hospital
$5,946,835
Attributed
$6,439,506
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,439,506 · 3
By mechanism
R01$5,543,106 · 2
K01$896,400 · 1
Top collaborators
- Kenneth Alan Freedberg1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Patrick Thomas Ellinor$17,149,392
- Jian Kong$24,736,613
- Bradley T Hyman$51,936,441
- Zhongcong Xie$19,705,169
- Anand Viswanathan$12,542,460
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAntiretroviral TherapyPreventionCost EffectivenessCaringMorbidity - Disease RateComorbidityModels And SimulationPoliciesDiagnosisMortalityClinical TrialsCardiovascular DiseasesCostAcquired Immunodeficiency SyndromeInternationalGeneral PopulationEpidemiologyClinical CareIncidenceCost EffectiveCost Effectiveness AnalysisCohortMultidisciplinary
Grant awards (16)
Optimizing HIV Care in Less Developed Countries$985,343
R01 · FY2025 · AI
The CHARMED model: a multimorbidity simulation model for people aging with HIV$589,717
R01 · FY2025 · AG · contact PI
The CHARMED model: a multimorbidity simulation model for people aging with HIV$628,678
R01 · FY2024 · AG · contact PI
The CHARMED model: a multimorbidity simulation model for people aging with HIV$26,898
R01 · FY2024 · AG · contact PI
The CHARMED model: a multimorbidity simulation model for people aging with HIV$686,122
R01 · FY2023 · AG · contact PI
The CHARMED model: a multimorbidity simulation model for people aging with HIV$411,830
R01 · FY2023 · AG · contact PI
The Impact of Hearing Loss Treatment Scale-Up in Persons Aging with HIV on Dementia Risk, Quality of Life, and Healthcare Costs$279,446
R01 · FY2023 · AG · contact PI
The CHARMED model: a multimorbidity simulation model for people aging with HIV$96,071
R01 · FY2023 · AG · contact PI
The CHARMED model: a multimorbidity simulation model for people aging with HIV$710,665
R01 · FY2022 · AG · contact PI
The CHARMED model: a multimorbidity simulation model for people aging with HIV$420,000
R01 · FY2022 · AG · contact PI
The CHARMED model: a multimorbidity simulation model for people aging with HIV$708,336
R01 · FY2021 · AG · contact PI
Cardiovascular Disease in South African HIV Patients: Value of Prevention$179,280
K01 · FY2020 · HL · contact PI
Cardiovascular Disease in South African HIV Patients: Value of Prevention$179,280
K01 · FY2019 · HL · contact PI
Cardiovascular Disease in South African HIV Patients: Value of Prevention$179,280
K01 · FY2018 · HL · contact PI
Cardiovascular Disease in South African HIV Patients: Value of Prevention$179,280
K01 · FY2017 · HL · contact PI
Cardiovascular Disease in South African HIV Patients: Value of Prevention$179,280
K01 · FY2016 · HL · contact PI